Literature DB >> 15948125

Transformation of follicular lymphoma to Burkitt-like lymphoma within a single lymph node.

Sanjay Mukhopadhyay1, Joseph Readling, Philip D Cotter, Anthony E Shrimpton, Jagmohan S Sidhu.   

Abstract

Aberrant expression of bcl-2 , caused by a t(14;18) translocation, is most commonly associated with follicular lymphoma. In a subset of these tumors, additional acquisition of a translocation involving c-myc leads to transformation to a high-grade lymphoma. We report a case of follicular lymphoma containing a t(14;18) translocation transforming into a Burkitt-like lymphoma containing the original t(14;18) as well as an additional t(8;14). The latter translocation resulted in the phenotype of Burkitt-like lymphoma, and the transformation from follicular lymphoma to Burkitt-like lymphoma was demonstrable within a single lymph node. To the best of our knowledge, this is the first report of a case documenting direct transformation of follicular lymphoma into Burkitt-like lymphoma in the same lymph node. This case illustrates the dramatic oncogenic stimulus that results from the inhibition of apoptosis by bcl-2 combined with the deregulation of cell growth by c-myc .

Entities:  

Mesh:

Year:  2005        PMID: 15948125     DOI: 10.1016/j.humpath.2005.01.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

2.  Concurrent development of "Burkitt-like" lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center origin.

Authors:  Hiroshi Kobayashi; Motoshi Ichikawa; Akira Hangaishi; Yoichi Imai; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-12-25       Impact factor: 2.490

Review 3.  MYC and the control of apoptosis.

Authors:  Steven B McMahon
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

4.  Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma.

Authors:  Toshiki Yamada; Takeshi Hara; Naoe Goto; Hitoshi Iwata; Hisashi Tsurumi
Journal:  Int J Hematol       Date:  2019-03-11       Impact factor: 2.490

5.  Risk Factors of Follicular Lymphoma.

Authors:  Shuangge Ma
Journal:  Expert Opin Med Diagn       Date:  2012-05-08

Review 6.  Atypical Burkitt's lymphoma transforming from follicular lymphoma.

Authors:  Yu Y Hwang; Florence Loong; Lap P Chung; Chor S Chim
Journal:  Diagn Pathol       Date:  2011-07-08       Impact factor: 2.644

Review 7.  Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer.

Authors:  Walter Douglas Fairlie; Erinna F Lee
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

8.  Burkitt lymphoma masquerading as cardiac tamponade.

Authors:  Pankaj Kaul; Kalyana Javangula
Journal:  J Cardiothorac Surg       Date:  2007-07-05       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.